Arlo Radtke

1.1k total citations
19 papers, 555 citations indexed

About

Arlo Radtke is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Arlo Radtke has authored 19 papers receiving a total of 555 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Surgery, 9 papers in Pulmonary and Respiratory Medicine and 6 papers in Cancer Research. Recurrent topics in Arlo Radtke's work include Testicular diseases and treatments (10 papers), Sarcoma Diagnosis and Treatment (5 papers) and Urologic and reproductive health conditions (4 papers). Arlo Radtke is often cited by papers focused on Testicular diseases and treatments (10 papers), Sarcoma Diagnosis and Treatment (5 papers) and Urologic and reproductive health conditions (4 papers). Arlo Radtke collaborates with scholars based in Germany, Austria and Denmark. Arlo Radtke's co-authors include Gazanfer Belge, Klaus‐Peter Dieckmann, Cord Matthies, Christian Wülfing, Christoph Oing, Petra Anheuser, Thomas Balks, Christian Ruf, Meike Spiekermann and Werner Wosniok and has published in prestigious journals such as Scientific Reports, International Journal of Molecular Sciences and European Urology.

In The Last Decade

Arlo Radtke

19 papers receiving 548 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Arlo Radtke Germany 14 329 205 171 136 135 19 555
Gernot W. Wolkersdörfer Germany 17 318 1.0× 264 1.3× 137 0.8× 80 0.6× 22 0.2× 34 752
Anthony Rizzo United States 9 72 0.2× 64 0.3× 103 0.6× 45 0.3× 48 0.4× 16 375
Libing Shi China 14 137 0.4× 39 0.2× 141 0.8× 53 0.4× 301 2.2× 31 745
Hyeung Ju Park United States 16 155 0.5× 38 0.2× 151 0.9× 23 0.2× 60 0.4× 25 713
Ming Yuan China 16 78 0.2× 36 0.2× 240 1.4× 108 0.8× 527 3.9× 58 950
Deyan Dzhenkov Bulgaria 11 85 0.3× 85 0.4× 100 0.6× 76 0.6× 33 0.2× 55 437
Yubin Wu China 9 45 0.1× 78 0.4× 100 0.6× 44 0.3× 22 0.2× 38 380
Florina Vasilescu Romania 10 124 0.4× 55 0.3× 100 0.6× 35 0.3× 32 0.2× 38 404
Naoki Murao Japan 13 195 0.6× 71 0.3× 67 0.4× 16 0.1× 21 0.2× 51 509
Omonigho Aisagbonhi United States 9 119 0.4× 69 0.3× 235 1.4× 46 0.3× 24 0.2× 29 455

Countries citing papers authored by Arlo Radtke

Since Specialization
Citations

This map shows the geographic impact of Arlo Radtke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arlo Radtke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arlo Radtke more than expected).

Fields of papers citing papers by Arlo Radtke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arlo Radtke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arlo Radtke. The network helps show where Arlo Radtke may publish in the future.

Co-authorship network of co-authors of Arlo Radtke

This figure shows the co-authorship network connecting the top 25 collaborators of Arlo Radtke. A scholar is included among the top collaborators of Arlo Radtke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arlo Radtke. Arlo Radtke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Dieckmann, Klaus‐Peter, et al.. (2022). Serum Levels of MicroRNA-371a-3p (M371) Can Predict Absence or Presence of Vital Disease in Residual Masses After Chemotherapy of Metastatic Seminoma. Frontiers in Oncology. 12. 889624–889624. 8 indexed citations
2.
Dieckmann, Klaus‐Peter, Arlo Radtke, Cord Matthies, et al.. (2021). Associations of serum levels of microRNA-371a-3p (M371) with risk factors for progression in nonseminomatous testicular germ cell tumours clinical stage 1. World Journal of Urology. 40(2). 317–326. 8 indexed citations
3.
Belge, Gazanfer, et al.. (2020). Serum levels of microRNA-371a-3p are not elevated in testicular tumours of non-germ cell origin. Journal of Cancer Research and Clinical Oncology. 147(2). 435–443. 24 indexed citations
4.
Mirastschijski, Ursula, Vincent Coger, Carmela Rianna, et al.. (2020). Lung Surfactant Accelerates Skin Wound Healing: A Translational Study with a Randomized Clinical Phase I Study. Scientific Reports. 10(1). 2581–2581. 15 indexed citations
5.
6.
Mirastschijski, Ursula, Blaž Lupše, Kathrin Maedler, et al.. (2019). Matrix Metalloproteinase-3 is Key Effector of TNF-α-Induced Collagen Degradation in Skin. International Journal of Molecular Sciences. 20(20). 5234–5234. 45 indexed citations
7.
Belge, Gazanfer, et al.. (2019). Serum Level of microRNA-375-3p Is Not a Reliable Biomarker of Teratoma. In Vivo. 34(1). 163–168. 32 indexed citations
8.
Radtke, Arlo, K.‐P. Dieckmann, Andrea Salzbrunn, et al.. (2019). Expression of miRNA‐371a‐3p in seminal plasma and ejaculate is associated with sperm concentration. Andrology. 7(4). 469–474. 31 indexed citations
9.
Driesche, Sander van den, Arlo Radtke, Gazanfer Belge, et al.. (2019). Microfluidic oxygen sensor system as a tool to monitor the metabolism of mammalian cells. Sensors and Actuators B Chemical. 289. 24–31. 17 indexed citations
10.
Radtke, Arlo, et al.. (2018). The Novel Biomarker of Germ Cell Tumours, Micro-RNA-371a-3p, Has a Very Rapid Decay in Patients with Clinical Stage 1. Urologia Internationalis. 100(4). 470–475. 52 indexed citations
11.
Anheuser, Petra, Arlo Radtke, Christian Wülfing, et al.. (2017). Serum Levels of MicroRNA371a-3p: A Highly Sensitive Tool for Diagnosing and Staging Testicular Germ Cell Tumours: A Clinical Case Series. Urologia Internationalis. 99(1). 98–103. 25 indexed citations
12.
Radtke, Arlo, Jann‐Frederik Cremers, Sabine Kliesch, et al.. (2017). Can germ cell neoplasia in situ be diagnosed by measuring serum levels of microRNA371a-3p?. Journal of Cancer Research and Clinical Oncology. 143(11). 2383–2392. 30 indexed citations
13.
Radtke, Arlo, et al.. (2017). The Synthetic Cannabinoid WIN 55,212-2 Elicits Death in Human Cancer Cell Lines. Anticancer Research. 37(11). 6341–6345. 25 indexed citations
14.
Dieckmann, Klaus‐Peter, Arlo Radtke, Meike Spiekermann, et al.. (2016). Serum Levels of MicroRNA miR-371a-3p: A Sensitive and Specific New Biomarker for Germ Cell Tumours. European Urology. 71(2). 213–220. 147 indexed citations
15.
16.
Markowski, Dominique Nadine, Burkhard Helmke, Arlo Radtke, et al.. (2012). Fibroid explants reveal a higher sensitivity against MDM2-inhibitor nutlin-3 than matching myometrium. BMC Women s Health. 12(1). 2–2. 8 indexed citations
17.
Mohamed, Salah A., et al.. (2012). Elevation of Matrix Metalloproteinases in Different Areas of Ascending Aortic Aneurysms in Patients with Bicuspid and Tricuspid Aortic Valves. The Scientific World JOURNAL. 2012. 1–7. 21 indexed citations
18.
Mohamed, Salah A., Arlo Radtke, J. Bullerdiek, et al.. (2012). Locally Different Endothelial Nitric Oxide Synthase Protein Levels in Ascending Aortic Aneurysms of Bicuspid and Tricuspid Aortic Valve. Cardiology Research and Practice. 2012. 1–8. 33 indexed citations
19.
Belge, Gazanfer, Arlo Radtke, Anke Meyer, et al.. (2011). Upregulation of the high mobility group AT-hook 2 gene in acute aortic dissection is potentially associated with endothelial-mesenchymal transition.. PubMed. 26(8). 1029–37. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026